PRELUDE CAPITAL MANAGEMENT, LLC - AXOVANT GENE THERAPIES LTD ownership

Back to all holdings Add to watchlist

AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AXOVANT GENE THERAPIES LTD
ValueSharesWeighting
Q3 2020$157,000
+214.0%
34,000
+89.9%
0.01%
+166.7%
Q2 2020$50,000–17,900–0.00%–
 Download
Other shareholders

There were no reported owners of AXOVANT GENE THERAPIES LTD in Q4 2020.

NameSharesValueWeighting ↓
View complete list of AXOVANT GENE THERAPIES LTD shareholders